Tuebingen
Germany
8
2015-09-17
5
2016-04-19
These are the the leading inventors for applications assigned to CUREVAC GMBH:
CUREVAC GMBH based in Tuebingen, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
COMPLEXATION OF NUCLEIC ACIDS WITH DISULFIDE-CROSSLINKED CATIONIC COMPONENTS FOR TRANSFECTION AND IMMUNOSTIMULATION
#2 | 2015-02-05Pharmaceutical composition comprising a polymeric carrier cargo complex and an antigen
#3 | 2014-10-02 ✅ Patent 9,314,535 granted on 2016-04-19Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
#4 | 2013-12-19 ✅ Patent 9,623,095 granted on 2017-04-18Vaccination in newborns and infants
#5 | 2013-11-07VACCINATION IN ELDERLY PATIENTS
#6 | 2013-10-24 ✅ Patent 9,737,595 granted on 2017-08-22Combination of vaccination and inhibition of MHC class I restricted antigen presentation
#7 | 2013-10-03 ✅ Patent 9,421,255 granted on 2016-08-23Vaccine composition comprising complexed immunostimulatory nucleic acids and antigens packaged with disulfide-linked polyethyleneglycol/peptide conjugates
#8 | 2012-08-30 ✅ Patent 8,703,906 granted on 2014-04-22Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
Also check out CureVac GmbH's (Tuebingen, Germany) applicant profile with 1 patent applications submitted.
41245 ⎘